IRUBIS GmbH
IRUBIS GmbH, founded in 2017, developed Monipa to speed up biological drug market entry using process analytical technology.
Introduction
IRUBIS GmbH, a Munich-based startup co-founded by Anja Müller, Alexander Geißler, and Lorenz Sykora-Mirle in 2017, has innovated with Monipa to expedite the development and market introduction of biological drugs. Monipa represents a transformative process analytical technology that enhances the efficiency and effectiveness of this critical pharmaceutical area.

Information
Categories
More Websites


Beijing Huffington Post imports high-end diagnostic reagents for microbial and food safety, focusing on quality and integrity.